OXY
42
17
D
32
10
JCI
44
7
INTC
35
4
GILD
55
5
ORLY
48
3
PBI
30
-8
SBUX
29
-2
CAT
47
3
PSA
43
6
PHM
44
4
ABT
54
4
DFS
64
4
INTU
54
2
UPS
51
6
CA
19
6
PDCO
77
3
AKAM
50
2
LRCX
56
4
OMC
37
2
OXY
42
17
D
32
10
JCI
44
7
INTC
35
4
GILD
55
5
ORLY
48
3
PBI
30
-8
SBUX
29
-2
CAT
47
3
PSA
43
6
PHM
44
4
ABT
54
4
DFS
64
4
INTU
54
2
UPS
51
6
CA
19
6
PDCO
77
3
AKAM
50
2
LRCX
56
4
OMC
37
2
Financhill
Back

Aytu BioPharma Quote, Financials, Valuation and Earnings

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
17

AYTU
Aytu BioPharma

Last Price:
$1.36
Seasonality Move:
154.39%

7 Day Trial

ALL ACCESS PASS

$ 7

How to Turn the AI Energy Crisis into BIG Profits

And investors who move now into one technology could make a whole lot of money.

Aytu BioPharma Price Quote

$1.36
-0.03 (-1.45%)
(Updated: December 21, 2024 at 5:16 AM ET)

Aytu BioPharma Key Stats

Sell
17
Aytu BioPharma (AYTU) is a Sell
Day range:
$1.35 - $1.44
52-week range:
$1.30 - $3.45
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.12
P/B ratio:
0.29%
Volume:
25.2K
Avg. volume:
46.2K
1-year change:
-51.4%
Market cap:
$8.5M
Revenue:
$81M
EPS:
$-1.53

How Much Does Aytu BioPharma Make?

Data Unavailable

Is Aytu BioPharma Growing As A Company?

Data Unavailable

Aytu BioPharma Stock Price Performance

  • Did Aytu BioPharma Stock Go Up Last Month?
    Aytu BioPharma share price went down by -6.71% last month
  • Did AYTU's Share Price Rise Over The Last Year?
    AYTU share price fell by -51.4% over the past 1 year

What Is Aytu BioPharma 52-Week High & Low?

Aytu BioPharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Aytu BioPharma?

Data Unavailable

Is Aytu BioPharma Cash Flow Positive?

Data Unavailable

Aytu BioPharma Return On Invested Capital

Data Unavailable

Aytu BioPharma Earnings Date & Stock Price

Aytu BioPharma Competitors

  • Who Are Aytu BioPharma's Competitors?
    Below is a list of companies who compete with Aytu BioPharma or are related in some way:
    • Achieve Life Sciences Inc (ACHV)
    • Bristol-Myers Squibb Co (BMY)
    • CEL-SCI Corp (CVM)
    • enVVeno Medical Corp (NVNO)
    • Telesis Bio Inc (TBIO)

Aytu BioPharma Dividend Yield

Data Unavailable

Aytu BioPharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: -6.98% 20.38%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable